WeVote

Bill

Bill

SB 1655

RELATING TO MANUFACTURED HEMP PRODUCTS.

2026 Regular Session Introduced by Stanley Chang and 1 co-sponsor

Hawaii bill establishes manufacturing standards, labeling requirements, and testing protocols for hemp-derived products to ensure consumer safety and market regulation.

Carried over to 2026 Regular Session.
0
WeVote Research Nonpartisan
Bill Summary · SB 1655

Legislative bill overview

SB 1655 establishes regulatory frameworks and standards for manufactured hemp products in Hawaii, likely addressing production, labeling, testing, and sales requirements for hemp-derived consumer goods. The bill appears designed to create a comprehensive system for oversight of the expanding hemp industry while ensuring product safety and consumer protection.

Why is this important

Hawaii's hemp industry has grown significantly, but without clear state regulations, products vary widely in quality, potency, and safety standards. Establishing formal manufacturing requirements protects consumers from contaminated or mislabeled products and provides businesses with clear compliance guidelines, while generating potential tax revenue and legitimate market growth.

Potential points of contention

  • Regulatory burden on small producers: Stringent manufacturing and testing requirements could disadvantage small-scale hemp farmers and manufacturers relative to larger operations with resources for compliance
  • Scope of regulated products: Unclear whether regulations apply to all hemp derivatives (CBD, Delta-8, Delta-10, etc.) or only specific products, which could create market confusion or unintended loopholes
  • Conflict with federal oversight: Hemp products exist in a complex federal-state legal space; state regulations may conflict with FDA guidance or create enforcement ambiguities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.